RxDoctor Payments Data

Lehi Vang

Hematology & Oncology · Tulsa, OKNPI 1548075492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 8.8% — the pattern of someone who eats at a lot of different presentations.

$3,651in general payments, 2019–2025

Across 160 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$323
  • AbbVie$305
  • AstraZeneca$243
  • Pharmacosmos Therapeutics Inc.$197
  • Genentech USA, Inc.$191
  • Novartis$146
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,47495%
  • Education$1775%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,651 in reported general payments places this provider in the 65th percentile of 118 hematology & oncology providers in Oklahoma.

See all hematology & oncology providers in Oklahoma

Other hematology & oncology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →